Chlamydia Infections: all 123 studies
Page 2 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- Trachoma Amelioration in Northern Amhara (TANA)CompletedNCT00322972Phase 4
- Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women.CompletedNCT00283127Not applicable
- Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV InfectionCompletedNCT00262106Phase 3
- Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea InfectionsCompletedNCT00252096Not applicable
- Trachoma Elimination Follow-upCompletedNCT00221364Phase 4
- Lay Health Advisors for Sexually Transmitted Disease PreventionCompletedNCT00207506Phase 1/2
- The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.CompletedNCT00207493Phase 1/2
- Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSMCompletedNCT00187902
- Home Screening for Chlamydia SurveillanceCompletedNCT00177437Phase 3
- Multi-level Interventions for STD Prevention Among AdolescentsTerminatedNCT00146406Not applicable
- Using the Healthcare Visit to Improve Contraceptive UseCompletedNCT00140296Not applicable
- Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia InfectionCompletedNCT00132457Not applicable
- Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the CommunityStatus unknownNCT00124878Phase 3
- Cellulose Sulfate (CS) Gel and HIV in NigeriaTerminatedNCT00120770Phase 3
- Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory DiseaseCompletedNCT00115388Not applicable
- Partner Notification for Chlamydia in Primary CareCompletedNCT00112255Phase 3
- Hormonal Contraception and Risk of Chlamydia and GonorrheaTerminatedNCT00091728
- Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IICompletedNCT00037388
- Infection and Cardiovascular DiseaseCompletedNCT00005547
- Inflammation, Infection, and Future Cardiovascular RiskCompletedNCT00005496
- Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic InfectionsCompletedNCT00001890Phase 2
- Clinical Trial of Eye Prophylaxis in the NewbornCompletedNCT00000120Phase 3